Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction
Authors:
- 14 October 2022
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 196 (3) , 657-664
Abstract
Purpose Immediate lymphatic reconstruction (ILR) at the time of axillary lymph node dissection (ALND) can reduce the incidence of lymphedema in patients with breast cancer. The oncologic safety of ILR is unknown and has not been reported. The purpose of this study was to evaluate if ILR is associated with increased breast cancer recurrence rates. Methods Patients with breast cancer who underwent ALND with ILR from September 2016 to December 2020 were identified from a prospective institutional database. Patient demographics, tumor characteristics, and operative details were recorded. Follow-up included the development of local recurrence as well as distant metastasis. Oncologic outcomes were analyzed. Results A total of 137 patients underwent ALND with ILR. At cancer presentation, 122 patients (89%) had clinically node positive primary breast cancer, 10 patients (7.3%) had recurrent breast cancer involving the axillary lymph nodes, 3 patients (2.2%) had recurrent breast cancer involving both the breast and axillary nodes, and 2 patients (1.5%) presented with axillary disease/occult breast cancer. For surgical management, 103 patients (75.2%) underwent a mastectomy, 22 patients (16%) underwent lumpectomy and 12 patients (8.8%) had axillary surgery only. The ALND procedure, yielded a median of 15 lymph nodes pathologically identified (range 3–41). At a median follow-up of 32.9 months (range 6–63 months), 17 patients (12.4%) developed a local (n = 1) or distant recurrence (n = 16), however, no axillary recurrences were identified. Conclusion Immediate lymphatic reconstruction in patients with breast cancer undergoing ALND is not associated with short term axillary recurrence and appears oncologically safe.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Prospective Study Evaluating Oncological Safety of Axillary Reverse MappingAnnals of Surgical Oncology, 2014
- Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristicsBritish Journal of Cancer, 2014
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysisThe Lancet Oncology, 2013
- A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patientsCancer, 2010
- Lymphedema Microsurgical Preventive Healing Approach: A New Technique for Primary Prevention of Arm Lymphedema After MastectomyAnnals of Surgical Oncology, 2009
- Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literatureEuropean Journal of Surgical Oncology, 2008
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective MeasurementsJournal of Clinical Oncology, 2008
- Combined Axillary Reverse Mapping (ARM) Technique for Breast Cancer Patients Requiring Axillary DissectionAnnals of Surgical Oncology, 2008
- Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic PreservationAnnals of Surgical Oncology, 2007
- Axillary Recurrence After a Negative Sentinel NodeBiopsy for Breast Cancer: Incidence and Clinical SignificanceAnnals of Surgical Oncology, 2004